Brief: Pulse Biosciences Announces Strategic Change Of Focus In Support Of Additional Opportunities For Medicinal Related Nano-Pulse Stimulation

Pulse Biosciences

20/09/2022 21:31

Sept 20 (Reuters) - Pulse Biosciences Inc  PLSE.O :
    * PULSE BIOSCIENCES ANNOUNCES STRATEGIC CHANGE OF FOCUS IN
SUPPORT
OF SIGNIFICANT ADDITIONAL OPPORTUNITIES FOR MEDICINAL RELATED
NANO-PULSE STIMULATION
    * PULSE BIOSCIENCES INC - ROBERT DUGGAN AND COMPANY ENTER
INTO A
$65 MILLION LOAN AGREEMENT
    * PULSE BIOSCIENCES - KEVIN DANAHY, APPOINTED CHIEF
EXECUTIVE
OFFICER; FORMER CHIEF EXECUTIVE OFFICER DARRIN UECKER TO SERVE
AS CHIEF TECHNOLOGY OFFICER
    * PULSE BIOSCIENCES INC - ROBERT W. DUGGAN APPOINTED AS
EXECUTIVE
CHAIRMAN
    * PULSE BIOSCIENCES INC - CO'S HEADCOUNT NOW STANDS AT 66
EMPLOYEES
    * PULSE BIOSCIENCES INC - ALONG WITH MINIMIZING COMMERCIAL
ACTIVITIES, COMPANY PLANS TO EVALUATE POTENTIAL PARTNERS IN
DERMATOLOGY SPACE
    * PULSE BIOSCIENCES - VAST MAJORITY OF PRESENT TIME
REDUCTION IN
PERSONNEL MAINLY IMPACTS DERMATOLOGICAL SALES, MARKETING &
RELATED SUPPORT ACTIVITIES

Source text for Eikon:  ID:nBw2FKKkha 
Further company coverage:  PLSE.O